Graham Capital Management »

4d Molecular Therapeutics In shares owned by Graham Capital Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $381k 51k 7.50

More positions owned by Graham Capital Management

Strategy Cl A New (MSTR)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Applied Digital Corp Note 2.750% 6/0 (Principal)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Fidelity Wise Origin Bitcoin SHS Put Option (FBTC)
Sunrun Note 4.000% 3/0 (Principal)
Purecycle Technologies Note 7.250% 8/1 (Principal)
Rivian Automotive Note 3.625%10/1 (Principal)
Green Plains Note 5.250%11/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
The Realreal Debt 4.000% 2/1 (Principal)
Groupon Note 4.875% 6/3 (Principal)
Amazon (AMZN)
Calumet Put Option (CLMT)
Eos Energy Enterprises Com Cl A (EOSE)

View all positions for Graham Capital Management

Top funds holding 4d Molecular Therapeutics In

Graham Capital Management

View all funds holding 4d Molecular Therapeutics In